Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,300 | N/A | 61,500 | 40,000 | 16,000 |
| Depreciation Amortization | 6,800 | N/A | 18,400 | 12,000 | 6,000 |
| Income taxes - deferred | 11,400 | N/A | -1,000 | 1,900 | 2,700 |
| Accounts receivable | -3,600 | N/A | -32,200 | -13,900 | -1,500 |
| Accounts payable and accrued liabilities | -5,300 | N/A | -6,400 | -6,200 | 2,600 |
| Other Working Capital | -33,900 | N/A | -43,300 | -25,300 | -30,400 |
| Other Operating Activity | 24,100 | 0 | 92,500 | 51,100 | 11,600 |
| Operating Cash Flow | $29,800 | $N/A | $89,500 | $59,600 | $7,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,000 | N/A | -21,900 | -17,500 | -11,500 |
| Net Acquisitions | N/A | N/A | -20,100 | N/A | N/A |
| Purchase Of Investment | -21,800 | N/A | -55,100 | -22,600 | -5,900 |
| Sale Of Investment | 31,800 | N/A | 140,800 | 80,500 | 67,600 |
| Other Investing Activity | 0 | 0 | 0 | -21,600 | -22,700 |
| Investing Cash Flow | $9,000 | $N/A | $43,700 | $18,800 | $27,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,800 | N/A | 25,600 | 20,200 | 15,100 |
| Common Stock Repurchased | -38,000 | N/A | -165,900 | -103,900 | -45,600 |
| Other Financing Activity | 0 | 0 | 3,200 | 2,600 | 1,700 |
| Financing Cash Flow | $-15,200 | $N/A | $-137,100 | $-81,100 | $-28,800 |
| Exchange Rate Effect | -300 | N/A | -5,700 | -2,400 | -700 |
| Beginning Cash Position | 64,100 | N/A | 64,800 | 64,800 | 64,800 |
| End Cash Position | 87,400 | N/A | 55,200 | 59,700 | 69,800 |
| Net Cash Flow | $23,300 | $N/A | $-9,600 | $-5,100 | $5,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,800 | N/A | 89,500 | 59,600 | 7,000 |
| Capital Expenditure | -1,000 | N/A | -21,900 | -17,500 | -11,500 |
| Free Cash Flow | 28,800 | 0 | 67,600 | 42,100 | -4,500 |